Perrigo

Perrigo

Pharmaceuticals
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm’s product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

$2.2B

Market Cap • 11/20/2026

2013

(13 years)

Founded

1991

(35 years ago)

IPO

NYSE

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

0,9

P/S

0,5

P/EBITDA

—

P/OCF

9,2

P/FCF

13,2

P/E

—

BVPS

17,6

EPS

—

Market Cap

Market Cap

2,2B

EV

5,1B

EV/Revenue

1,2

EV/EBITDA

-4

EV/EBIT

-3,1

Payout

Dividend Per Share

1,2

Dividend Yield

7,3%

Buyback Yield

0,3%

Total Yield

7,6%

Dividend Yield 5Y

7%

Payout

-9,1%

Retained Earnings

-4B

Profitability

Gross Margin

32,3%

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

2,2%

Capex/Revenue

1,8%

Capex/D&A

20,9%

Capex/OCF

30,1%

SBC/OCF

18,4%

% PPE

13%

% Goodwill

22,7%

ROE

—

ROIC

—

Growth

CAGR Revenue 5Y

-1,1%

CAGR Net Income 5Y

51,7%

CAGR EPS 5Y

46,8%

CAGR OCF 5Y

-8,4%

Leverage

N.D./EBITDA

—

Debt/Equity

0%

Current Ratio

2,4

Quick Ratio

1,1

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium